There was no statistically significant difference in the expression level of NKG2D in gastric cancer (STAD), cholangiocarcinoma (CHOL), and pancreatic cancer (PAAD) compared with the corresponding normal tissues (Figure 1C). The gene discussed is KLRK1; the disease is gastric cancer.